Literature DB >> 30692272

Reactive Oxygen Species Signaling Promotes Hypoxia-Inducible Factor 1α Stabilization in Sonic Hedgehog-Driven Cerebellar Progenitor Cell Proliferation.

Chad R Potts1, M Hope Robinson1,2, Nicholas W Eyrich1,2, Victor Maximov1, Anna M Kenney3,2,4.   

Abstract

Cerebellar development is a highly regulated process involving numerous factors acting with high specificity, both temporally and by location. Part of this process involves extensive proliferation of cerebellar granule neuron precursors (CGNPs) induced by Sonic Hedgehog (SHH) signaling, but downstream effectors of mitogenic signaling are still being elucidated. Using primary CGNP cultures, a well-established model for SHH-driven proliferation, we show that SHH-treated CGNPs feature high levels of hypoxia-inducible factor 1α (HIF1α), which is known to promote glycolysis, stemness, and angiogenesis. In CGNPs cultured under normoxic conditions, HIF1α is posttranslationally stabilized in a manner dependent upon reactive oxygen species (ROS) and NADPH oxidase (NOX), both of which are also upregulated in these cells. Inhibition of NOX activity resulted in HIF1α destabilization and reduced levels of cyclin D2, a marker of CGNP proliferation. As CGNPs are the putative cells of origin for the SHH subtype of medulloblastoma and aberrant SHH signaling is implicated in other neoplasms, these studies may also have future relevance in the context of cancer. Taken together, our findings suggest that a better understanding of nonhypoxic HIF1α stabilization through NOX-induced ROS generation can provide insights into normal cell proliferation in cerebellar development and SHH-driven cell proliferation in cancers with aberrant SHH signaling.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  Sonic Hedgehog; hypoxia-inducible factor 1a; medulloblastoma; reactive oxygen species; stem cells

Mesh:

Substances:

Year:  2019        PMID: 30692272      PMCID: PMC6447416          DOI: 10.1128/MCB.00268-18

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  66 in total

1.  Constitutive NADPH oxidase 4 activity resides in the composition of the B-loop and the penultimate C terminus.

Authors:  Katharina von Löhneysen; Deborah Noack; Patti Hayes; Jeffrey S Friedman; Ulla G Knaus
Journal:  J Biol Chem       Date:  2012-01-25       Impact factor: 5.157

Review 2.  The suffocating kidney: tubulointerstitial hypoxia in end-stage renal disease.

Authors:  Imari Mimura; Masaomi Nangaku
Journal:  Nat Rev Nephrol       Date:  2010-09-28       Impact factor: 28.314

Review 3.  Hypoxia signalling in cancer and approaches to enforce tumour regression.

Authors:  Jacques Pouysségur; Frédéric Dayan; Nathalie M Mazure
Journal:  Nature       Date:  2006-05-25       Impact factor: 49.962

4.  The NADPH Oxidase Nox4 mediates tumour angiogenesis.

Authors:  V Helfinger; N Henke; S Harenkamp; M Walter; J Epah; C Penski; M Mittelbronn; K Schröder
Journal:  Acta Physiol (Oxf)       Date:  2015-11-20       Impact factor: 6.311

Review 5.  NADPH oxidase-mediated redox signaling: roles in cellular stress response, stress tolerance, and tissue repair.

Authors:  Fan Jiang; Yun Zhang; Gregory J Dusting
Journal:  Pharmacol Rev       Date:  2011-01-12       Impact factor: 25.468

6.  Oxidized low-density lipoprotein (oxLDL) triggers hypoxia-inducible factor-1alpha (HIF-1alpha) accumulation via redox-dependent mechanisms.

Authors:  Vladimir A Shatrov; Vadim V Sumbayev; Jie Zhou; Bernhard Brüne
Journal:  Blood       Date:  2003-02-13       Impact factor: 22.113

7.  Immunoregulatory Protein B7-H3 Reprograms Glucose Metabolism in Cancer Cells by ROS-Mediated Stabilization of HIF1α.

Authors:  Sangbin Lim; Hao Liu; Luciana Madeira da Silva; Ritu Arora; Zixing Liu; Joshua B Phillips; David C Schmitt; Tung Vu; Steven McClellan; Yifeng Lin; Wensheng Lin; Gary A Piazza; Oystein Fodstad; Ming Tan
Journal:  Cancer Res       Date:  2016-04-05       Impact factor: 12.701

8.  Hedgehog and PI-3 kinase signaling converge on Nmyc1 to promote cell cycle progression in cerebellar neuronal precursors.

Authors:  Anna Marie Kenney; Hans R Widlund; David H Rowitch
Journal:  Development       Date:  2003-12-03       Impact factor: 6.868

9.  NADPH oxidase 4 mediates insulin-stimulated HIF-1α and VEGF expression, and angiogenesis in vitro.

Authors:  Dan Meng; Aihong Mei; Junxu Liu; Xueling Kang; Xianglin Shi; Ruizhe Qian; Sifeng Chen
Journal:  PLoS One       Date:  2012-10-29       Impact factor: 3.240

10.  Copper activates HIF-1α/GPER/VEGF signalling in cancer cells.

Authors:  Damiano Cosimo Rigiracciolo; Andrea Scarpelli; Rosamaria Lappano; Assunta Pisano; Maria Francesca Santolla; Paola De Marco; Francesca Cirillo; Anna Rita Cappello; Vincenza Dolce; Antonino Belfiore; Marcello Maggiolini; Ernestina Marianna De Francesco
Journal:  Oncotarget       Date:  2015-10-27
View more
  4 in total

1.  Microarray Analysis of Gene Expression Provides New Insights Into Denervation-Induced Skeletal Muscle Atrophy.

Authors:  Yuntian Shen; Ru Zhang; Liang Xu; Qiuxian Wan; Jianwei Zhu; Jing Gu; Ziwei Huang; Wenjing Ma; Mi Shen; Fei Ding; Hualin Sun
Journal:  Front Physiol       Date:  2019-10-11       Impact factor: 4.566

Review 2.  Basic mechanisms of peripheral nerve injury and treatment via electrical stimulation.

Authors:  Xiao-Lei Chu; Xi-Zi Song; Qi Li; Yu-Ru Li; Feng He; Xiao-Song Gu; Dong Ming
Journal:  Neural Regen Res       Date:  2022-10       Impact factor: 6.058

Review 3.  It takes two to tango: Widening our understanding of the onset of schizophrenia from a neuro-angiogenic perspective.

Authors:  Bárbara S Casas; David Arancibia-Altamirano; Franco Acevedo-La Rosa; Delia Garrido-Jara; Vera Maksaev; Dan Pérez-Monje; Verónica Palma
Journal:  Front Cell Dev Biol       Date:  2022-08-24

4.  High-resolution transcriptional landscape of xeno-free human induced pluripotent stem cell-derived cerebellar organoids.

Authors:  Samuel Nayler; Devika Agarwal; Fabiola Curion; Rory Bowden; Esther B E Becker
Journal:  Sci Rep       Date:  2021-06-21       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.